1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells

Biochemical and Biophysical Research Communications

Volumn 407, Issue 4, 2011, Pages 699-702

  Geldmeyer Hilt, Kerstin ^a   Heine, Guido ^a,b   Hartmann, Björn ^a   Baumgrass, Ria ^b   Radbruch, Andreas ^b   Worm, Margitta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

Calcitriol; Na ve B cells; NF B; Vitamin D; Vitamin D receptor

Indexed keywords

CALCITRIOL; CD40 ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P105; PROTEIN P50; SYNAPTOTAGMIN I; VITAMIN D RECEPTOR;

ARTICLE; B LYMPHOCYTE ACTIVATION; BINDING KINETICS; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG MECHANISM; GENE INDUCTION; HUMAN; HUMAN CELL; MEMORY CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; B-LYMPHOCYTES; CALCITRIOL; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; TRANSCRIPTION FACTOR RELA;

EID: 79955015334     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.078     Document Type: Article

References (26)

1. Wang T.-T., Tavera-Mendoza L.E., Laperriere D., Libby E., Burton MacLeod N., Nagai Y., Bourdeau V., Konstorum A., Lallemant B., Zhang R., Mader S., White J.H. Large-scale in silico and microarray-based identification of direct 1, 25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 2005, 19:2685-2695.
2. Adams J.S., Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4:80-90.
3. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 2008.
4. Cohen-Lahav M., Shany S., Tobvin D., Chaimovitz C., Douvdevani A. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol. Dial. Transplant. 2006, 21:889-897.
5. Szeto F.L., Sun J., Kong J., Duan Y., Liao A., Madara J.L., Li Y.C. Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts. J. Steroid Biochem. Mol. Biol. 2007, 103:563-566.
6. Litonjua A.A., Weiss S.T. Is vitamin D deficiency to blame for the asthma epidemic?. J. Allergy Clin. Immunol. 2007, 120:1031-1035.
7. Hyppönen E., Läärä E., Reunanen A., Järvelin M.-R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
8. Becker A., Fischer R., Schneider M. Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Zeitschrift für Rheumatologie 2001, 60:352-358.
9. Heine G., Anton K., Henz B.M., Worm M. 1Alpha, 25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur. J. Immunol. 2002, 32:3395-3404.
10. Sha W.C., Liou H.-C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-[kappa]B leads to multifocal defects in immune responses. Cell 1995, 80:321-330.
11. Chen C.-L., Singh N., Yull F.E., Strayhorn D., Van Kaer L., Kerr L.D. Lymphocytes lacking I{kappa}B-{alpha} develop normally, but have selective defects in proliferation and function. J. Immunol. 2000, 165:5418-5427.
12. Milovanovic M., Heine G., Hallatschek W., Opitz B., Radbruch A., Worm M. Vitamin D receptor binds to the [epsilon] germline gene promoter and exhibits transrepressive activity. J. Allergy Clin. Immunol. 2010, 126(5):1016-1023.
13. Weise C., Hilt K., Milovanovic M., Ernst D., Ruhl R., Worm M. Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFkappaB pathway in human B cells. J. Nutr. Biochem. 2010.
14. Heine G., Niesner U., Chang H.D., Steinmeyer A., Zugel U., Zuberbier T., Radbruch A., Worm M. 1, 25-Dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 2008, 38:2210-2218.
15. Klein U., Rajewsky K., Kuppers R. Human immunoglobulin (Ig)M+IgD+peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 1998, 188:1679-1689.
16. Morgan J.W., Kouttab N., Ford D., Maizel A.L. Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology 2000, 141:3225-3234.
17. Yu X.P., Bellido T., Manolagas S.C. Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1, 25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA 1995, 92:10990-10994.
18. Cogswell P.C., Scheinman R.I., Baldwin A.S. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL. J. Immunol. 1993, 150:2794-2804.
19. Ten R.M., Paya C.V., Israel N., Le Bail O., Mattei M.G., Virelizier J.L., Kourilsky P., Israel A. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. EMBO J. 1992, 11:195-203.
20. Morgan J.W., Sliney D.J., Morgan D.M., Maizel A.L. Differential regulation of gene transcription in subpopulations of human B lymphocytes by vitamin D3. Endocrinology 1999, 140:381-391.
21. Oeckinghaus A., Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harbor Perspect. Biol. 2009, 1:a000034.
22. Sun J., Mustafi R., Cerda S., Chumsangsri A., Xia Y.R., Li Y.C., Bissonnette M. Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells. J. Steroid Biochem. Mol. Biol. 2008, 111:37-40.
23. Tse A.K., Wan C.K., Shen X.L., Zhu G.Y., Cheung H.Y., Yang M., Fong W.F. 1, 25-Dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB. Exp. Cell Res. 2007, 313:1722-1734.
24. Riis J.L., Johansen C., Gesser B., Moller K., Larsen C.G., Kragballe K., Iversen L. 1Alpha, 25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression. Arch. Dermatol. Res. 2004, 296:195-202.
25. Tan X., Wen X., Liu Y. Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF-{kappa}B Signaling. J. Am. Soc. Nephrol. 2008.
26. Adams L.S., Teegarden D. 1, 25-Dihydroxycholecalciferol inhibits apoptosis in C3H10T1/2 murine fibroblast cells through activation of nuclear factor kappaB. J. Nutr. 2004, 134:2948-2952.